克隆片段DNA用于测定Epstein-Barr病毒基因组拷贝数

本文报道用非标记的克隆 EBV DNA 限制性酶解片段作标准,同时以标记的克隆片段R 作探针,经 DNA 点杂交检测每个 H_(18)细胞中 EBV 基因组拷贝数。由于实验中结合用 W 片段作标准 DNA 和探针,测定每个 Raji 细胞中所具有稳定的 EBV 基因组拷贝数,以及每个 Raji 细胞中 EBV 基因组的重复序列 W 片段数均与前人报告的结果基本一致,所以说明了本文所用方法及结果的可靠性。此项技术可在病毒阳性细胞培养物中定量测定病毒核酸,也可用于临床分子病毒学作为常规的核酸杂交技术。     

乙型肝炎病毒多聚酶末端蛋白的结构和功能研究

乙肝病毒蛋白结构和功能是当前研究乙肝病毒的热点之一。HBV多聚酶的末端蛋白在病毒复制过程中起重要作用,主要包括前基因组RNA包装和DNA合成的蛋白引发等,并可抑制细胞对干扰素的反应。本文综述了乙肝病毒多聚酶末端蛋白的结构和功能,还比较了乙肝病毒与逆转录病毒多聚酶结构和功能的异同。     

RNA病毒的复制途径

ＲＮＡ病毒的复制途径聂剑初（北京师范大学生物学系１００８７５）ＤＮＡ病毒在其基因组复制和表达过程中利用许多的宿主蛋白质。ＲＮＡ病毒的复制则面临一个特殊的问题,即未受侵染的宿主细胞没有按照ＲＮＡ模板的指令合成ＲＮＡ的酶。因此,ＲＮＡ病毒必须含有合成这类...     

动物细胞DNA多聚酶

该书分十部分:一、引言;二、动物细胞中DNA多聚酶的增殖;三、αDNA多聚酶;四、βDNA多聚酶;五、r及σDNA多聚酶;六、动物细胞DNA多聚酶在细胞DNA复制中的作用七、动物细胞DNA多聚酶在细胞DNA修复中的作用;八、DNA合成的精确性;九、动物细胞DNA多聚酶的生物学;十、展望.     

EBV裂解复制周期调控机制研究新进展

EBV与许多恶性疾病包括霍奇金病、伯基特淋巴瘤、鼻咽癌等恶性肿瘤发病有关人类B淋巴细胞是EBV天然宿主,其在宿主细胞中的生活周期分为潜伏感染和裂解感染。EBV潜伏感染时,为逃避宿主细胞的免疫杀伤,仅表达少量基因产物。而在外界条件如化学、物理或宿主细胞分化的刺激下,EBV可由潜伏感染进入到裂解复制(Lytic Replication)感染周期,促进病毒在宿主细胞中播散。根据EBV裂解复制产物出现的时间顺序可将裂解复制周期分为裂解复制立即早期、早期和晚期。1 EBV裂解复制不同时期产物的调控作用     

病毒酶的研究及其进展

病毒的主要生物学特性之一是只有一种类型的核酸为其基因组(RNA或DNA),并必须在活细胞中增殖。虽然病毒复制需要细胞组分参与,但病毒基因编码的酶在病毒复制中的作用已日益受到重视。各种不同的病毒具有不同的病毒酶,包括复制核的酶、整合人细胞染色体的整合酶、引发(priming)DNA     

家蚕浓核病毒 (中国镇江株)在不同感受性宿主体内的复制

家蚕浓核病毒中国镇江株是一株双生浓核病毒(bidensovirus)。其宿主感染后的病症与典型的家蚕浓核病毒(BmDNV-1伊那株)表现相似,病蚕软化,中肠的圆筒型细胞呈浓核症。该病毒的最大特点是基因组中含有二套DNA分子(VD1,VD2),这两种核酸分子以单链( VD1,-VD1, VD2,-VD2)线型方式被分开包装在各自的衣壳蛋白中,成为四种病毒体,而且它自身编码DNA聚合酶。有部分蚕品种对该病毒表现完全抗性,即不发病。分别对敏感性家蚕品种(华八35)和抗性家蚕品种(秋丰d)的幼虫进行经口接种病毒。在接种后,从2h到96h分9个时间点,对中肠组织进行取样。以家蚕细胞质肌动蛋白A3(actinA3)基因作为参比基因,用来标定取样组织细胞数。针对VD1和VD2分别设计特异引物,用荧光定量PCR的方法分别检测各个时间点的样品中的病毒基因组VD1和VD2拷贝数。结果表明:无论是在感性还是在抗性宿主体内,家蚕浓核病毒中国株的基因组VD1和VD2在各时间点拷贝数相近,表现出VD1和VD2是同步复制的;病毒侵入两种宿主中肠的初始量(接种后2h)基本相等,每个细胞约为6~10拷贝数。在敏感性宿主体内病毒感染过程表现为潜伏期,指数增长期,平台期。从接种后2h到12h为病毒潜伏期;12h到36h为指数增长期,倍增时间为1·71h,大约扩增15次;36h到96h为平台期,进入平台期病毒的拷贝数达到20万个。在抗性宿主体内病毒处于一种极低水平的增殖,从添毒后2h的6~10拷贝数到96h的150~200拷贝数,病毒复制倍增时间分别为3h和12h,大约扩增5次。推测家蚕对浓核病毒中国株的抗病性,只是一种慢性的带毒不发病的表现。     

鼻咽癌转移淋巴结中EB病毒相关的DNA多聚酶的分离及其特性研究

一种新的DNA多聚酶已从鼻咽癌(NPC)转移淋巴结胞核酶液,通过DEAE-纤维素柱层析而被部分纯化,并可与细胞的α-及β-DNA多聚酶分开。 此酶有下列特点可与细胞DNA多聚酶区分:(1)可放DEAE-纤维素吸附,需用130mMK_2HPO_4缓冲液方可洗脱下来。(2)可被浓盐所激活,150——200mMKCl或75mM(NH_4)_2SO_4可使它显示最高的酶活性。(3)最适pH为8.0。(4)对磷酰甲酸盐的抑制较敏感。(5)能很好地利用某些合成模板,如poly(dA)·oligo(dT)_(10)及poly(dA)·oligo(dT)_(12-18)。但不能利用poly(rA)·oligo(dT)_(10),证明此酶并非细胞的γ-DNA多聚酶,而与巴基特淋巴瘤的EB病毒相关的(EBV)DNA多聚酶性质十分相似。对照的Raji细胞未见此种EBV-DNA多聚酶。 从鼻咽癌淋巴结中分离出此种EBV-DNA多聚酶,将对EB病毒与NPC的发病关系提供新的证据。     

口蹄疫病毒前导蛋白的研究进展

FMDV基因组编码的所有蛋白质是以多聚蛋白质的形式产生的。前导蛋白是FMDV基因组编码的第一个具有酶切活性的蛋白质。它是剪切多聚蛋白质的共翻译分子内部的一个蛋白酶。FMDV是在多聚蛋白质的N端剪切前导蛋白。此外,前导蛋白不仅能剪切病毒编码的多聚蛋白,而且能降解宿主细胞中特定的蛋白质,由此极大提高了病毒的毒力。前导蛋白可以抑制I型干扰素的分泌,降低免疫监视系统对FMDV的监视能力,以此逃避宿主的非特异性免疫系统的攻击。关于前导蛋白与细胞凋亡的关系,细胞凋亡产生的eIF4G片段与前导蛋白裂解eIF4G产生的碎片是不同的。     

HIV-1整合酶的功能及其抑制剂的研究进展

I型人类免疫缺陷病毒（human immunodeflciency virustype1,HIV-1）在宿主细胞内经逆转录得到的cDNA,由整合酶（integrase,ry）催化插入到宿主基因组DNA中,该过程称为整合过程。整合是HIV-1复制周期中不可缺少的步骤,对于病毒的复制至关重要,因此对整合酶的抑制能够有效地起到抗HIV的作用。该文综述了整合酶的结构与功能以及目前关于整合酶抑制剂的最新研究进展。     

Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid.

DNA synthesis in Epstein-Barr virus (EBV)-infected lymphocytes was inhibited by phosphonoacetic acid (PAA) as measured by [3H]thymidine incorporation. PAA, at a concentration of 200 microgram/ml, inhibited [3H]thymidine incorporation by human umbilical cord lymphocytes infected with EBV strain P94 but had little effect on DNA synthesis in mitogen-stimulated cells. Transformed cell lines did not develop from infected cord cell cultures treated with 100 microgram of PAA per ml. Cytofluorometric analysis showed marked increases in cellular nucleic acid content (RNA plus DNA) as early as 9 days after infection of cord cells in the absence of PAA and before significant enhancement of [3H]thymidine incorporation became apparent. Moreover, EBV led to increases in cellular nucleic acid even when 200 microgram of PAA per ml was added to cell cultures before infection. The apparent discrepancy between results obtained by [3H]thymidine incorporation and cytofluorometry is explained either by significant inhibition of cellular DNA polymerases by PAA or by a block at the G2 + M phase of the cell cycle. The data suggest that EBV initiates alterations in cellular nucleic acid synthesis or cell division without prior replication of viral DNA by virus-induced DNA polymerases.     

人鼻咽组织中Epstein-Barr病毒基因组存在状态的分析

Burkitt淋巴瘤和未分化型鼻咽癌的细胞中存在着Epstein-Barr病毒(EBV)的基因组,在前者虽经长期体外培养,病毒基因组仍持续存在,并部分地表达。这些现象提示,至少有一些EBV基因组是整合在寄主细胞的DNA中。Kieff等用染色体原位杂交检测Burkitt淋巴瘤Namalwa细胞株和EBV转化的人脐带血B淋巴细胞IB_4株,发现病毒DNA是整合在前者的1号染色体上,在后者则整合     

Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication.

The effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus (EBV) DNA replication in the lymphoblastoid cell lines P3HR-1 and Raji is reported. Acyclovir at a concentration of 100 microM completely inhibited EBV DNA synthesis in superinfected Raji cells, but did not inhibit DNA synthesis in mock-infected cells. The number of EBV genome equivalents per cell in the virus-producing cell line P3HR-1 was significantly reduced by acyclovir, whereas the number of latent EBV genomes in Raji cells was not affected by the drug. In situ cytohybridization performed on untreated P3HR-1 cultures revealed the presence of relatively large amounts of EBV DNA in 15 to 20% of the cells. After a 100 microM drug treatment, no P3HR-1 cells contained levels of EBV DNA detectable by in situ cytohybridization. Indirect immunofluorescence studies demonstrated that during treatment with 100 microM acyclovir for 7 days, the percentage of P3HR-1 cells expressing viral capsid antigen was reduced. The EBV DNA remaining in P3HR-1 cells after treatment with 100 microM acyclovir (approximately 14 genomes per cell) had the properties of covalently closed circular DNA with an average molecular weight of 108 X 10(6), as determined by contour length measurements.     

Purification and characterization of varicella-zoster virus-induced DNA polymerase.

Infection of WI-38 human fibroblasts with varicella-zoster virus led to the stimulation of host cell DNA polymerase synthesis and induction of a new virus-specific DNA polymerase. This virus-induced DNA polymerase was partially purified and separated from host cell enzymes by DEAE-cellulose and phosphocellulose column chromatographies. This virus-induced enzyme could be distinguished from host cell enzyme by its chromatographic behavior, template specificity, and its requirement of salt for maximal activity. The enzyme could efficiently use poly(dC).oligo(dG)12-18 as well as poly(dA).oligo(dT)12-18 as template-primers. It required Mg2+ for maximal polymerization activity and was sensitive to phosphonoacetic acid, to which host alpha- and beta-DNA polymerase were relatively resistant. In addition, this induced DNA polymerase activity was enhanced by adding 60 mM (NH4)2SO4 to the reaction mixture.     

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.

The effect of the nucleoside analog 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine) on herpes simplex virus type 1 DNA synthesis was examined. Acycloguanosine inhibited herpesvirus DNA synthesis in virus-infected cells. The synthesis of host cell DNA was only partially inhibited in actively growing cells at acycloguanosine concentrations several hundred-fold greater than the 50% effective dose for herpes simplex virus type 1. Studies using partially purified enzymes revealed that the triphosphate of this compound inhibited the virus-induced DNA polymerases (DNA nucleotidyltransferases) to a greater degree than the DNA polymerase of the host cell, that the inhibition was dependent upon the base composition of the template, and that the triphosphate was a better substrate for the virus-induced polymerases than for the alpha cellular DNA polymerases.     

Preferential Inhibition of Herpes-Group Viruses by Phosphonoacetic Acid: Effect on Virus DNA Synthesis and Virus-Induced DNA Polymerase Activity

In tissue culture phosphonoacetic acid (PAA) specifically inhibited DNA synthesis of human cytomegalovirus (CMV), murine CMV, simian CMV, Epstein-Barr virus, and Herpesvirus saimiri. Fifty to one hundred micrograms per milliliter PAA completely inhibited viral DNA synthesis with no significant damage to host cell DNA synthesis. In vitro DNA polymerization assays showed that 10 μg/ml of PAA specifically inhibited partially purified human CMV-induced DNA polymerase, while little inhibition of host-cell DNA polymerase activity was found. The specific inhibition of herpes-group virus DNA synthesis with little toxicity to host cells suggests that PAA has great potential as an antiherpesvirus therapeutic agent.     

Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.

Human lymphoblastoid Raji cells, which do not produce virus, supported replication of Epstein-Barr virus (EBV) upon superinfection. Early antigen, viral capsid antigen, and virions were produced in Raji cells superinfected with EBV. Viral DNA replicated under complete inhibition of host cell DNA synthesis to the extent that a few micrograms of EBV DNA were recovered from 107 superinfected Raji cells, corresponding to 5,000 viral genomes/cell. Homology of the synthesized viral DNA to parental EBV DNA was more than 90%. Virions produced by the Raji cells contained a 55S DNA but failed to induce early antigen, viral capsid antigen, and viral DNA synthesis after a second superinfection of Raji cells.     

Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state

This paper presents data on the effects of interferon treatment on Epstein-Barr virus (EBV) gene expression in latently infected Daudi Burkitt's lymphoma cells, and reviews the possible role of viral gene products in the regulation of translation. In Daudi cells the main virally coded RNAs are the small untranslated RNAs EBER-1 and EBER-2, two mRNAs for the DNA binding protein EBNA-1, and a number of small RNAs containing sequences from the BamHI W repeat region of the viral genome. Interferon treatment does not change the qualitative pattern of EBV gene expression but decreases the levels of the EBNA-1 mRNAs. The chromatographic behaviour of EBV-encoded RNAs on CF11-cellulose indicates that many contain double-stranded regions; these RNAs co-purify with RNA that activates the interferon-induced, dsRNA-sensitive protein kinase DAI. Computer analysis indicates that the exons transcribed from the BamHI W repeats have the potential for formation of very stable secondary structures. Many viruses can counteract the inhibition of protein synthesis mediated by the DAI-catalysed phosphorylation of initiation factor eIF-2 and our data suggest that the small RNA EBER-1 may fulfil this function in the EBV system. During the infection and immortalization of B lymphocytes by EBV the synthesis of large amounts of EBER-1 RNA might thus allow the virus to circumvent one of the interferon-mediated mechanisms of host cell defence.     

Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.

Epstein-Barr virus (EBV) from a nasopharyngeal carcinoma (NPC) hybrid cell line (NPC-KT) lacking defective viral DNA molecules superinfected Raji cells and induced EBV early antigens (EA), as did virus from P3HR-1 cells, which contained defective molecules. The EBV polypeptides induced by NPC-KT appeared to be identical to those induced by P3HR-1 virus. The ability of NPC-KT virus to induce EA was enhanced more than 10-fold by treatment of superinfected cells with dimethyl sulfoxide; however, dimethyl sulfoxide treatment did not enhance superinfection by P3HR-1 virus. After infection, DNA synthesis of both the superinfecting NPC-KT virus and the resident Raji viral genome was induced. In addition to amplified Raji EBV episomal DNA, a fused terminal fragment of NPC-KT viral DNA was detected. The detection of fused terminal DNA fragments suggests that the superinfecting virion DNA either circularizes or polymerizes after superinfection and is possibly amplified through circular or concatenated replicative intermediates.